127 related articles for article (PubMed ID: 15006425)
1. Production of the soluble human Fas ligand by Dictyostelium discoideum cultivated on a synthetic medium.
Lu Y; Knol JC; Linskens MH; Friehs K; Van Haastert PJ; Flaschel E
J Biotechnol; 2004 Mar; 108(3):243-51. PubMed ID: 15006425
[TBL] [Abstract][Full Text] [Related]
2. Long-term production of soluble human Fas ligand through immobilization of Dictyostelium discoideum in a fibrous bed bioreactor.
Chen J; Chen H; Zhu X; Lu Y; Yang ST; Xu Z; Cen P
Appl Microbiol Biotechnol; 2009 Feb; 82(2):241-8. PubMed ID: 19015846
[TBL] [Abstract][Full Text] [Related]
3. [Expression of the soluble human Fas ligand in Dictyostelium discoideum].
Wu XX; Lu YH; Li QB; Deng X; Xu ZN
Sheng Wu Gong Cheng Xue Bao; 2005 May; 21(3):380-4. PubMed ID: 16108360
[TBL] [Abstract][Full Text] [Related]
4. NaCS-PDMDAAC immobilized cultivation of recombinant Dictyostelium discoideum for soluble human Fas ligand production.
Zheng C; Zeng X; Danquah MK; Lu Y
Biotechnol Prog; 2015; 31(2):424-30. PubMed ID: 25504805
[TBL] [Abstract][Full Text] [Related]
5. Cultivation of immobilized Dictyostelium discoideum for the production of soluble human Fas ligand.
Lu Y; Knol JC; Linskens MH; Friehs K; van Haastert PJ; Flaschel E
Appl Microbiol Biotechnol; 2004 Oct; 65(5):547-52. PubMed ID: 15146296
[TBL] [Abstract][Full Text] [Related]
6. Efficient expression and primary purification of 6-his tagged human Fas ligand in Dictyostelium discoideum.
Chen J; Lu Y; Xu Z; Cen P; Fang X
Biotechnol Lett; 2007 Jun; 29(6):859-63. PubMed ID: 17351714
[TBL] [Abstract][Full Text] [Related]
7. Comparison of a production process in a membrane-aerated stirred tank and up to 1000-L airlift bioreactors using BHK-21 cells and chemically defined protein-free medium.
Hesse F; Ebel M; Konisch N; Sterlinski R; Kessler W; Wagner R
Biotechnol Prog; 2003; 19(3):833-43. PubMed ID: 12790647
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the behaviour of Dictyostelium discoideum in immobilised state by means of continuous cultivation.
Beshay U; Friehs K; Azzam AE; Flaschel E
Bioprocess Biosyst Eng; 2003 Dec; 26(2):117-22. PubMed ID: 14566554
[TBL] [Abstract][Full Text] [Related]
9. Perfusion culture of hybridoma cells for hyperproduction of IgG(2a) monoclonal antibody in a wave bioreactor-perfusion culture system.
Tang YJ; Ohashi R; Hamel JF
Biotechnol Prog; 2007; 23(1):255-64. PubMed ID: 17269696
[TBL] [Abstract][Full Text] [Related]
10. [High-cell density cultivation of recombinant Escherichia coli for production of TRAIL by using a 2-stage feeding strategy].
Zhang Y; Shen YL; Xia XX; Sun AY; Wei DZ; Zhou JS; Zhang GJ; Wang LH; Jiao BH
Sheng Wu Gong Cheng Xue Bao; 2004 May; 20(3):408-13. PubMed ID: 15971615
[TBL] [Abstract][Full Text] [Related]
11. Efficient long-term and high-yielded production of a recombinant proteoglycan in eukaryotic HEK293 cells using a membrane-based bioreactor.
Adam E; Sarrazin S; Landolfi C; Motte V; Lortat-Jacob H; Lassalle P; Delehedde M
Biochem Biophys Res Commun; 2008 May; 369(2):297-302. PubMed ID: 18261977
[TBL] [Abstract][Full Text] [Related]
12. Process development for a recombinant Chinese hamster ovary (CHO) cell line utilizing a metal induced and amplified metallothionein expression system.
Huang EP; Marquis CP; Gray PP
Biotechnol Bioeng; 2004 Nov; 88(4):437-50. PubMed ID: 15459913
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of multicellular development switches cell death of Dictyostelium discoideum towards mammalian-like unicellular apoptosis.
Tatischeff I; Petit PX; Grodet A; Tissier JP; Duband-Goulet I; Ameisen JC
Eur J Cell Biol; 2001 Jun; 80(6):428-41. PubMed ID: 11484934
[TBL] [Abstract][Full Text] [Related]
14. Wave microcarrier cultivation of MDCK cells for influenza virus production in serum containing and serum-free media.
Genzel Y; Olmer RM; Schäfer B; Reichl U
Vaccine; 2006 Aug; 24(35-36):6074-87. PubMed ID: 16781022
[TBL] [Abstract][Full Text] [Related]
15. New miniaturized hollow-fiber bioreactor for in vivo like cell culture, cell expansion, and production of cell-derived products.
Gloeckner H; Lemke HD
Biotechnol Prog; 2001; 17(5):828-31. PubMed ID: 11587570
[TBL] [Abstract][Full Text] [Related]
16. Recombinant antibody production by perfusion cultures of rCHO cells in a depth filter perfusion system.
Lee JC; Chang HN; Oh DJ
Biotechnol Prog; 2005; 21(1):134-9. PubMed ID: 15903250
[TBL] [Abstract][Full Text] [Related]
17. Process technology for production and recovery of heterologous proteins with Pichia pastoris.
Jahic M; Veide A; Charoenrat T; Teeri T; Enfors SO
Biotechnol Prog; 2006; 22(6):1465-73. PubMed ID: 17137292
[TBL] [Abstract][Full Text] [Related]
18. An actively mixed mini-bioreactor for protein production from suspended animal cells.
Diao J; Young L; Zhou P; Shuler ML
Biotechnol Bioeng; 2008 May; 100(1):72-81. PubMed ID: 18078290
[TBL] [Abstract][Full Text] [Related]
19. Production of human alpha-1-antitrypsin from transgenic rice cell culture in a membrane bioreactor.
McDonald KA; Hong LM; Trombly DM; Xie Q; Jackman AP
Biotechnol Prog; 2005; 21(3):728-34. PubMed ID: 15932249
[TBL] [Abstract][Full Text] [Related]
20. Production of recombinant plant gum with tobacco cell culture in bioreactor and gum characterization.
Xu J; Shpak E; Gu T; Moo-Young M; Kieliszewski M
Biotechnol Bioeng; 2005 Jun; 90(5):578-88. PubMed ID: 15818563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
